Science Explorer Back to mapMap

Most cited papers from Antaros Medical (Sweden)

What are the most cited papers from Antaros Medical (Sweden)?

The most cited paper from Antaros Medical (Sweden) is "Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study" (Jan W. Eriksson, Per Lundkvist, Per‐Anders Jansson et al., 2018), with 395 citations. Next come "An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)" (260) and "The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients" (252).

Showing 50 of 61 papers. Every paper with more than 21 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study Jan W. Eriksson, Per Lundkvist, Per‐Anders Jansson et al. · Diabetologia Open access 3 Jul 2018 395
2 An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD) Michèle Vacca et al. · Nature Metabolism Open access238 authors 12 Jun 2024 260
3 The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients Aino Latva‐Rasku, Miikka‐Juhani Honka, Joel Kullberg et al. · Diabetes Care 18 Mar 2019 252
4 Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial Fredrik Rosqvist, Joel Kullberg, Marcus Ståhlman et al. · The Journal of Clinical Endocrinology & Metabolism Open access Aug 2019 237
5 Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging Anne Flint, Grit Andersen, Paul Hockings et al. · Alimentary Pharmacology & Therapeutics Open access 27 Sep 2021 222
6 Transplantation of macroencapsulated human islets within the bioartificial pancreas βAir to patients with type 1 diabetes mellitus Per‐Ola Carlsson, Daniel Espes, Amir Sedigh et al. · American Journal of Transplantation Open access 29 Dec 2017 202
7 Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist Martin Bossart et al. · Cell Metabolism Open access 20 Dec 2021 178
8 The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases Ruben A Smith et al. · Nature Communications Open access 27 Oct 2023 149
9 Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA Nicholas M Selby et al. · Nephrology Dialysis Transplantation Open access 14 May 2018 149
10 Consensus-based technical recommendations for clinical translation of renal T1 and T2 mapping MRI Ilona A. Dekkers et al. · Magnetic Resonance Materials in Physics Biology and Medicine Open access 22 Nov 2019 114
11 Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study Jan Oscarsson, Kristina Önnerhag, Ulf Risérus et al. · Journal of clinical lipidology Open access 10 Aug 2018 111
12 Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study Rohit Seth Loomba, Eric Lawitz, Juan P. Frías et al. · ˜The œLancet. Gastroenterology & hepatology 12 Dec 2022 104
13 Automated analysis of liver fat, muscle and adipose tissue distribution from CT suitable for large-scale studies Joel Kullberg, Anders Hedström, John Brandberg et al. · Scientific Reports Open access 30 Aug 2017 92
14 A 6‐month randomized, double‐blind, placebo‐controlled trial of weekly exenatide in adolescents with obesity Daniel Weghuber et al. · Pediatric Obesity Open access 16 Feb 2020 79
15 The effect of ticagrelor on growth of small abdominal aortic aneurysms—a randomized controlled trial Anders Wanhainen, Kevin Mani, Joel Kullberg et al. · Cardiovascular Research 23 May 2019 72
16 Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo‐controlled, exploratory study Jonas Oldgren, Sanna Laurila, Axel Åkerblom et al. · Diabetes Obesity and Metabolism Open access 24 Feb 2021 64
17 Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study Gretha J. Boersma, Emil Johansson, Maria J. Pereira et al. · Hormone and Metabolic Research 12 Jul 2018 61
18 A concept for holistic whole body MRI data analysis, Imiomics Robin Strand, Filip Malmberg, Lars E.B. Johansson et al. · PLoS ONE Open access 27 Feb 2017 60
19 Automatic segmentation of large-scale CT image datasets for detailed body composition analysis Nouman Ahmad, Robin Strand, Björn Sparresäter et al. · BMC Bioinformatics Open access 18 Sep 2023 59
20 Fully convolutional networks for automated segmentation of abdominal adipose tissue depots in multicenter water–fat MRI Taro Langner, Anders Hedström, Katharina Mörwald et al. · Magnetic Resonance in Medicine Open access 12 Oct 2018 57
21 Inhibition of fatty acid synthase with FT‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non‐alcoholic fatty liver disease: Results from two early‐phase randomized trials Carine Beysen, Patricia E. Schroeder, Eric L. Wu et al. · Diabetes Obesity and Metabolism Open access 2 Dec 2020 55
22 Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes Victoria Parker, Darren C. Robertson, Edmundo Erazo‐Tapia et al. · Nature Metabolism Open access 8 Dec 2023 51
23 International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology Patrick Veit‐Haibach, Håkan K. Ahlström, Ronald Boellaard et al. · European Journal of Nuclear Medicine and Molecular Imaging Open access 25 Aug 2023 50
24 Separation of water and fat signal in whole‐body gradient echo scans using convolutional neural networks Jonathan Andersson, Håkan Ahlström, Joel Kullberg · Magnetic Resonance in Medicine Open access 29 Apr 2019 49
25 Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes Olof Eriksson, Torsten Haack, Youssef Hijazi et al. · Scientific Reports Open access 7 Oct 2020 46
26 An image registration method for voxel-wise analysis of whole-body oncological PET-CT Hanna Jönsson, Simon Ekström, Robin Strand et al. · Scientific Reports Open access 5 Nov 2022 43
27 Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial Mazen Noureddin, Shaharyar M. Khan, Francisco R. Portell et al. · ˜The œLancet. Gastroenterology & hepatology 5 Oct 2023 42
28 Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population Lars Lind, Lars E.B. Johansson, Håkan K. Ahlström et al. · World Journal of Hepatology Open access 23 Apr 2020 40
29 Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes Lars E.B. Johansson, Paul Hockings, EVA K. JOHNSSON et al. · Diabetes Obesity and Metabolism Open access 18 Feb 2020 40
30 Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects Anders Gummesson, Ulf Strömberg, Caroline Schmidt et al. · PLoS ONE Open access 22 Aug 2018 40
31 Validation of 18F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study Björg Jónsdóttir, M. Alemany Ripoll, Antonina Bergman et al. · Cancer Imaging Open access 13 Apr 2021 39
32 Consensus‐Based Technical Recommendations for Clinical Translation of Renal Phase Contrast MRI A de Boer et al. · Journal of Magnetic Resonance Imaging Open access 2 Nov 2020 39
33 Whole-Body Imaging of Tissue-specific Insulin Sensitivity and Body Composition by Using an Integrated PET/MR System: A Feasibility Study Emil Johansson, Mark Lubberink, Kerstin Heurling et al. · Radiology 28 Aug 2017 39
34 Serum levels of perfluoroalkyl substances (PFAS) and body composition – A cross-sectional study in a middle-aged population Peter Lind, Lars Lind, Samira Salihović et al. · Environmental Research Open access 22 Jan 2022 36
35 Identifying Morphological Indicators of Aging With Neural Networks on Large-Scale Whole-Body MRI Taro Langner, Johan Wikström, Tomas Bjerner et al. · IEEE Transactions on Medical Imaging Open access 30 Oct 2019 36
36 Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation Sarah Skeoch, Penny L. Hubbard Cristinacce, Helen Williams et al. · Scientific Reports Open access 5 Apr 2017 36
37 Albuminuria‐lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross‐over clinical study Annemarie B. van der Aart‐van der Beek, Ellen M. Apperloo, Niels Jongs et al. · Diabetes Obesity and Metabolism Open access 26 Feb 2023 31
38 Simulating the effect of cerebral blood flow changes on regional quantification of [ 18 F]flutemetamol and [ 18 F]florbetaben studies Fiona Heeman, Maqsood Yaqub, Isadora Lopes Alves et al. · Journal of Cerebral Blood Flow & Metabolism Open access 11 Apr 2020 31
39 Multiparametric magnetic resonance imaging allows non-invasive functional and structural evaluation of diabetic kidney disease Kianoush Makvandi, Paul Hockings, Gert Jensen et al. · Clinical Kidney Journal Open access 22 Feb 2022 29
40 A whole-body FDG PET/MR atlas for multiparametric voxel-based analysis Therese Sjöholm, Simon Ekström, Robin Strand et al. · Scientific Reports Open access 16 Apr 2019 29
41 Sedentary time has a stronger impact on metabolic health than moderate to vigorous physical activity in adolescents with obesity: a cross‐sectional analysis of the Beta‐JUDO study Valérie Julian, Peter Bergsten, Anders H. Forslund et al. · Pediatric Obesity 26 Jan 2022 28
42 Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease Michael Fridén, Fredrik Rosqvist, Håkan K. Ahlström et al. · Frontiers in Medicine Open access 10 Jan 2022 28
43 Effectively Measuring Exercise‐Related Variations in T1ρ and T2 Relaxation Times of Healthy Articular Cartilage Dimitri A. Kessler, James Mackay, Scott D. McDonald et al. · Journal of Magnetic Resonance Imaging Open access 16 Jul 2020 28
44 Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients—a description of the DAPACARD study Axel Åkerblom, Jonas Oldgren, Aino Latva‐Rasku et al. · Upsala Journal of Medical Sciences Open access 2 Jan 2019 27
45 Neuregulin-1 Induces Cardiac Hypertrophy and Impairs Cardiac Performance in Post–Myocardial Infarction Rats Magdalena Zurek, Edvin Johansson, M Dean Palmer et al. · Circulation Open access 28 Sep 2020 26
46 Dynamic contrast-enhanced MRI of synovitis in knee osteoarthritis: repeatability, discrimination and sensitivity to change in a prospective experimental study James Mackay, Faezeh Sanaei Nezhad, Tamam Rifai et al. · European Radiology Open access 16 Feb 2021 25
47 Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Cyrielle Caussy, Lars E.B. Johansson · Endocrinology Diabetes & Metabolism Open access 20 Apr 2020 25
48 [11C]5-hydroxy-tryptophan PET for Assessment of Islet Mass During Progression of Type 2 Diabetes Lina Carlbom, Daniel Espes, Mark Lubberink et al. · Diabetes Open access 28 Feb 2017 25
49 Three‐Dimensional Surface‐Based Analysis of Cartilage MRI Data in Knee Osteoarthritis: Validation and Initial Clinical Application James Mackay, Joshua Kaggie, Graham M. Treece et al. · Journal of Magnetic Resonance Imaging Open access 24 May 2020 24
50 Water-fat separation incorporating spatial smoothing is robust to noise Jonathan Andersson, Håkan K. Ahlström, Joel Kullberg · Magnetic Resonance Imaging Open access 27 Mar 2018 24

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.